These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 23378197)

  • 21. Impact of primary percutaneous coronary intervention on blood perfusion in nonculprit artery in patients with anterior ST elevation myocardial infarction.
    Wang J; Liu JH; Zheng B; Zhang M; Wang SP; Zheng Z
    Chin Med J (Engl); 2013 Jan; 126(1):22-6. PubMed ID: 23286472
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Usefulness of the platelet-to-lymphocyte ratio in predicting angiographic reflow after primary percutaneous coronary intervention in patients with acute ST-segment elevation myocardial infarction.
    Kurtul A; Yarlioglues M; Murat SN; Ergun G; Duran M; Kasapkara HA; Demircelik MB; Cetin M; Ocek AH
    Am J Cardiol; 2014 Aug; 114(3):342-7. PubMed ID: 24948493
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of Nonalcoholic Fatty Liver Disease on Myocardial Perfusion in Nondiabetic Patients Undergoing Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction.
    Emre A; Terzi S; Celiker E; Sahin S; Yazıcı S; Erdem A; Ceylan US; Asik M; Yesilcimen K
    Am J Cardiol; 2015 Dec; 116(12):1810-4. PubMed ID: 26506122
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association of lymphocyte-to-monocyte ratio with the no-reflow phenomenon in patients who underwent a primary percutaneous coronary intervention for ST-elevation myocardial infarction.
    Kurtul A; Yarlioglues M; Celik IE; Duran M; Elcik D; Kilic A; Oksuz F; Murat SN
    Coron Artery Dis; 2015 Dec; 26(8):706-12. PubMed ID: 26340546
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association of mean platelet volume and pre- and postinterventional flow with infarct-related artery in ST-segment elevation myocardial infarction.
    Elbasan Z; Gür M; Sahin DY; Kuloglu O; Icen YK; Turkoglu C; Ozkan B; Uysal OK; Kalkan GY; Cayli M
    Angiology; 2013 Aug; 64(6):440-6. PubMed ID: 22887730
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic value of neutrophil/lymphocyte ratio in patients with ST-elevated myocardial infarction undergoing primary coronary intervention: a prospective, multicenter study.
    Kaya MG; Akpek M; Lam YY; Yarlioglues M; Celik T; Gunebakmaz O; Duran M; Ulucan S; Keser A; Oguzhan A; Gibson MC
    Int J Cardiol; 2013 Sep; 168(2):1154-9. PubMed ID: 23219132
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Level of Selvester QRS score is predictive of ST-segment resolution and 30-day outcomes in patients with acute myocardial infarction undergoing primary coronary intervention.
    Uyarel H; Cam N; Okmen E; Kasikcioglu H; Tartan Z; Akgul O; Simsek D; Cetin M; Bozbeyoglu E; Buturak A; Uzunlar B
    Am Heart J; 2006 Jun; 151(6):1239.e1-7. PubMed ID: 16781226
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of Coronary Thrombectomy in Cardiogenic Shock Complicating ST-Segment Elevation Myocardial Infarction.
    Suzuki M; Sumiyoshi T; Miyachi H; Yamashita J; Yamasaki M; Miyauchi K; Yamamoto T; Nagao K; Tomoike H; Takayama M
    Am J Cardiol; 2015 Jun; 115(12):1649-54. PubMed ID: 25888301
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic impact of contrast-enhanced CMR early after acute ST segment elevation myocardial infarction (STEMI) in a regional STEMI network: results of the "Herzinfarktverbund Essen".
    Bruder O; Breuckmann F; Jensen C; Jochims M; Naber CK; Barkhausen J; Erbel R; Sabin GV;
    Herz; 2008 Mar; 33(2):136-42. PubMed ID: 18344033
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Endothelin-1 release in acute myocardial infarction as a predictor of long-term prognosis and no-reflow assessed by contrast-enhanced magnetic resonance imaging.
    Eitel I; Nowak M; Stehl C; Adams V; Fuernau G; Hildebrand L; Desch S; Schuler G; Thiele H
    Am Heart J; 2010 May; 159(5):882-90. PubMed ID: 20435200
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Elevated serum osteoprotegerin levels predict in-hospital major adverse cardiac events in patients with ST elevation myocardial infarction.
    Çanga A; Durakoğlugil ME; Erdoğan T; Kirbaş A; Yilmaz A; Çiçek Y; Ergül E; Çetin M; Kocaman SA
    J Cardiol; 2012 Nov; 60(5):355-60. PubMed ID: 22727437
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The prognostic value of serum gamma glutamyl transferase activity on admission in patients with STEMI undergoing primary PCI.
    Akpek M; Elcik D; Kalay N; Yarlioglues M; Dogdu O; Sahin O; Ardic I; Oguzhan A; Ergin A; Kaya MG
    Angiology; 2012 Nov; 63(8):579-85. PubMed ID: 22210739
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Effects of hemoglobin levels on long-term prognosis in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention].
    Wang CH; Jin XF; Fang Q; Zhang SY; Shen ZJ; Fan ZJ; Liu ZY; Xie HZ
    Zhonghua Yi Xue Za Zhi; 2011 Nov; 91(42):3003-6. PubMed ID: 22333029
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum B-type natriuretic peptide on admission can predict the 'no-reflow' phenomenon after primary drug-eluting stent implantation for ST-segment elevation myocardial infarction.
    Jeong YH; Kim WJ; Park DW; Choi BR; Lee SW; Kim YH; Lee CW; Hong MK; Kim JJ; Park SW; Park SJ
    Int J Cardiol; 2010 May; 141(2):175-81. PubMed ID: 19144424
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The significance of anaemia in patients with acute ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Bolińska S; Sobkowicz B; Zaniewska J; Chlebińska I; Boliński J; Milewski R; Tycińska A; Musiał W
    Kardiol Pol; 2011; 69(1):33-9. PubMed ID: 21267962
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prospective multicenter randomized trial comparing physician versus patient transfer for primary percutaneous coronary intervention in acute ST-segment elevation myocardial infarction.
    Zhang Q; Zhang RY; Qiu JP; Zhang JF; Wang XL; Jiang L; Liao ML; Zhang JS; Hu J; Yang ZK; Shen WF
    Chin Med J (Engl); 2008 Mar; 121(6):485-91. PubMed ID: 18364130
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term effects of drug-eluting stents versus bare metal stents on patients with acute ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: outcomes of 3-year clinical follow-up.
    Wang CH; Fang Q; Zhang SY; Shen ZJ; Fan ZJ; Jin XF; Zeng Y; Liu ZY; Xie HZ; Yang M
    Chin Med J (Engl); 2012 Aug; 125(16):2803-6. PubMed ID: 22932070
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Predictive values of bilirubin for in-hospital adverse events in patients with ST-segment elevation myocardial infarction after primary percutaneous coronary intervention.
    Ying C; Liu CF; Guo DQ; Du ZR; Wei YJ
    Clinics (Sao Paulo); 2023; 78():100306. PubMed ID: 37949037
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The impact of previous revascularization on clinical outcomes in patients undergoing primary percutaneous coronary intervention.
    Bench TJ; Parikh PB; Jeremias A; Brener SJ; Naidu SS; Shlofmitz RA; Pappas T; Marzo KP; Gruberg L
    J Invasive Cardiol; 2013 Apr; 25(4):166-9. PubMed ID: 23549488
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Post primary percutaneous coronary intervention no-reflow in patients with acute myocardial infarction: contributing factors and long-term prognostic impact].
    Han YL; Deng J; Jing QM; Wang SL; Ma YY; Luan B
    Zhonghua Xin Xue Guan Bing Za Zhi; 2006 Jun; 34(6):483-6. PubMed ID: 16842659
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.